First Share First Mistake, page-7

First 7 Last

Share
Profile

Follow
Disagree

402 Posts.

03/03/16

11:30

Post #: 17175349
Share

Originally posted by FaradayFaramir ↑

Hi Everyone

Please go easy on me because I am going to rant as a dumb beginner. When I first looked at buying shares two years (March 2014), I opened my nabTrade account and this "Recommendation" table appeared. It showed "ACR" as a buy. I didn't realised it was really a sponsored "Morningstar" rating. (Now they just say undervalued, fairly valued, over valued).

I looked at ACR and thought how interesting since February 2014, the share price had tanked. That Testosterone report linking it to heart attacks or strokes came out at that time. he value of the shares were hovering about $2 and some figure said its intrinsic value was $2.50. (Little did I know that value would keep dropping.)

Personally I thought that the negative testosterone report would blow over in time. Also previous Annual Reports and financial results looked very positive to me. There was a bonus dividend that year as well.

So I brought 1000 shares @ $1.955 on 11 Mar 2014 with free brokerage (intro offer). Then I brought another 170 shares @ $1.68 on 17 April 2014. I have a very low income, so $2,240.60 represented a fair bit of money to me. Thankfully it represented less than 10% of what I had plus I brought another better 9 stocks since that time.

During July 2014, a very positive report came out about Testosterone and the share price returned to my original purchase price. Stupidly I did not sell. I believed that the share price would not fall below $2 again. I looked on over the next number of months, watching the share price fall again.

So 16 Mar 2015, I did something stupid again, I averaged down and brought 610 shares @ $0.80. Total outlay of $2,743.55. After that I learnt that the management of prior 2014 when its good years were happening is different to the current management. Now my average is around $1.5413.

It may seem obvious to average down again but I would rather keep my money in an account earning interest waiting for a better stock; for example like when I brought SRX at $17.75 March 2015. It may seem obvious to all you experienced investors to cut my losses over approximately 57% or more.

Keeping ACR reminds me of how naive I was 2 years ago. It may reduced my overall portfolio gain but it is a lesson I am willing to learn. I did not sell back in July 2014 when I should have. I had this naive belief that ACR will turn itself around and return to its glory days. I now understand the term falling knife and value trap. I learnt the hard way. This stock and one oil stock is pulling my portfolio down but I know oil will turn around (another story for another thread.) As for ACR???? What would I know?????

All the experienced investors and traders can probably see a million faults in me that I cannot see yet. I doubt anyone of any influence would read this thread. So I feel safe about ranting about my mistake. (It will have no influence over today's share price - no one will listen to me). I guess I am even making that classic beginner's mistake of hanging onto a lost cause.

Thank you for reading. Please be constructive if you want to have a go at me. This was my very first share purchase. I plan to hold it forever as a reminder - rightly or wrongly.
PS: I planned to hold VED forever but it was acquired at a 48% profit for me. Can't see that happening with ACR.

Expand

All of the best investing/trading lessons come from losing money.

You should have cut your losses early but ACR is good value around 60c.

ACR Price at posting: 67.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 5 more messages in this thread...

First 7 Last

Add ACR (ASX) to my watchlist

(20min delay)
Last 5.3¢		Change -0.001(1.85%)		Mkt cap ! $15.40M

Open	High	Low	Value	Volume
5.4¢	5.4¢	5.3¢	$64	1.2K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	5.4¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	38947	1

View Market Depth

No.	Vol.	Price($)
1	10000	0.054
3	18707	0.053
2	293669	0.052
4	129304	0.051
2	217490	0.050

Price($)	Vol.	No.
0.057	38947	1
0.058	17258	1
0.059	18000	1
0.060	670	1
0.061	100000	1

Last trade - 09.59am 07/10/2024 (20 minute delay)

ACR (ASX) Chart

First Share First Mistake, page-7

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

First Share First Mistake, page-7

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News